These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9463305)

  • 21. Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor.
    Christie PE; Henderson WR
    Clin Allergy Immunol; 2002; 16():233-54. PubMed ID: 11577541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prostaglandins in cerebrovascular pathology].
    Pascu I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1985; 30(3):167-78. PubMed ID: 2935911
    [No Abstract]   [Full Text] [Related]  

  • 23. Prostanoids as pharmacological targets in COPD and asthma.
    Rolin S; Masereel B; Dogné JM
    Eur J Pharmacol; 2006 Mar; 533(1-3):89-100. PubMed ID: 16458293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nonsteroidal anti-inflammatory drugs--nephrotoxic mechanism of action].
    Sułowicz W; Stompór T; Tabor B
    Przegl Lek; 1999; 56(2):169-74. PubMed ID: 10375954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prostaglandins and the heart].
    Markov KhM
    Patol Fiziol Eksp Ter; 1987; (6):6-13. PubMed ID: 3328145
    [No Abstract]   [Full Text] [Related]  

  • 26. An update on eicosanoids and inhibitors of cyclooxygenase enzyme systems.
    Sharma S; Sharma SC
    Indian J Exp Biol; 1997 Oct; 35(10):1025-31. PubMed ID: 9475035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandins: their possible role in the pathogenesis of pulpal and periapical diseases, part 1.
    Torabinejad M; Bakland LK
    J Endod; 1980 Sep; 6(9):733-9. PubMed ID: 7005382
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute myocardial infarction and heart failure: role of apoptosis.
    Abbate A; Bussani R; Amin MS; Vetrovec GW; Baldi A
    Int J Biochem Cell Biol; 2006; 38(11):1834-40. PubMed ID: 16781883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The influence of prostaglandins on metastases development].
    Olszewska-Słonina D; Sopońska M; Drewa T; Olszewski K
    Pol Merkur Lekarski; 2003 Nov; 15(89):471-5. PubMed ID: 14969147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in a murine model of asthma.
    Landgraf RG; Nossi DF; Sirois P; Jancar S
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):163-72. PubMed ID: 17923399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?
    Wallace JL
    Physiol Rev; 2008 Oct; 88(4):1547-65. PubMed ID: 18923189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prostaglandins and inhibitors of their synthesis in occlusive vascular diseases].
    Viinikka L
    Duodecim; 1984; 100(16):1007-16. PubMed ID: 6510257
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanism of action of antiinflammatory drugs.
    Vane JR; Botting RM
    Int J Tissue React; 1998; 20(1):3-15. PubMed ID: 9561441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandins and sickness behavior: old story, new insights.
    Pecchi E; Dallaporta M; Jean A; Thirion S; Troadec JD
    Physiol Behav; 2009 Jun; 97(3-4):279-92. PubMed ID: 19275907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Coxibs: cyclooxygenase-2 inhibitors].
    Turnheim K
    Wien Klin Wochenschr; 2001 Aug; 113(15-16):558-65. PubMed ID: 11571832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitors of cyclooxygenases: mechanisms, selectivity and uses.
    Botting RM
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 5():113-24. PubMed ID: 17218763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prostanoids and leukotrienes in ophthalmology. II. Role of prostanoids and leukotrienes in the physiology and pathophysiology of the eye].
    Macek K; Havlícek K; Rehák S
    Cesk Oftalmol; 1990 Sep; 46(5):356-9. PubMed ID: 2225151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiological and pathophysiological aspects of cardiac prostaglandins.
    Karmazyn M; Dhalla NS
    Can J Physiol Pharmacol; 1983 Nov; 61(11):1207-25. PubMed ID: 6362803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandins and prostaglandin inhibitors in clinical practice.
    Sixma JJ
    Neth J Med; 1982; 25(1):2-5. PubMed ID: 7035977
    [No Abstract]   [Full Text] [Related]  

  • 40. COX-LOX inhibition: current evidence for an emerging new therapy.
    Skelly MM; Hawkey CJ
    Int J Clin Pract; 2003 May; 57(4):301-4. PubMed ID: 12800462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.